R&D-driven biopharma operating across vaccines, rare disease, oncology, and immunology
Sanofi is a large-scale pharmaceutical R&D operation spanning vaccines, rare diseases, oncology, neurology, and immunology, with 10,000+ employees across 25+ countries. The tech stack reveals dual operational modes: enterprise data/BI infrastructure (SAP ecosystem, Snowflake, Power BI, SAS) supporting manufacturing and regulatory work, layered with specialized pharma platforms (Veeva, SCADA, MES, DCS) for GMP compliance and site operations. Active hiring across sales (268), manufacturing (255), research (239), and healthcare (231) suggests simultaneous scaling of commercial execution, production capacity, clinical pipelines, and market access—a pattern consistent with launching new products while optimizing existing cost structures.
Notable leadership hires: Adjuvant Platform Head, Project Head, Head of Procurement, Order to Cash Project Lead, Regulatory Affairs Device Lead
Sanofi manufactures and develops medicines and vaccines across therapeutic areas including vaccines, rare blood disorders, neurology, immunology, oncology, diabetes, and cardiovascular disease. The company operates as an R&D-driven enterprise with manufacturing footprints and regulatory infrastructure spanning North America, Europe, and Asia-Pacific. Their pipeline is backed by internal discovery, clinical development programs, and go-to-market strategies for new product launches. Manufacturing and site operations run on specialized control systems (SCADA, DCS, PLCs, MES, OPC UA) integrated with enterprise SAP systems, reflecting the capital intensity and compliance rigor of pharmaceutical production at scale.
Enterprise: SAP, Snowflake, Salesforce Service Cloud, Power BI, SAS, Python, AWS, Azure. Manufacturing/Operations: SCADA, DCS, PLCs, MES, OPC UA, Siemens TIA Portal, WinCC. Pharma: Veeva (platforms and Vault), HANA, Informatica. Adopting: SAP S/4HANA, WalkMe, Pendo, Tungsten.
GMP compliance assurance, accelerating drug discovery and development timelines, process standardization and inefficiencies, regulatory requirement management, cost optimization (including COGS improvement), and reducing pressure on healthcare systems.
Other companies in the same industry, closest in size